Cancer Research UK logo.
SearchDonate
  • Search

A trial of cyclophosphamide, dexamethasone and ixazomib for myeloma (MUK 8)

Overview

Cancer types:

Myeloma

Status:

Results

Phase:

Phase 2

Details

This trial was for people whose myeloma had come back or whose treatment had stopped working.

The trial was open for people to join between 2016 and 2018. The team published some results in 2022.

Recruitment start: 1 January 2016

Recruitment end: 21 December 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Gordon Cook

Supported by

Experimental Cancer Medicine Centre (ECMC)

Myeloma UK

NIHR Clinical Research Network: Cancer

Takeda Oncology

University of Leeds

Last reviewed: 12 February 2025

CRUK internal database number: 13908

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.